RESUMO
A novel approach, i.e., Continuous Material Deposition on Filaments (CMDF), for the incorporation of active materials within 3D-printed structures is presented. It is based on passing a filament through a solution in which the active material is dissolved together with the polymer from which the filament is made. This enables the fabrication of a variety of functional 3D-printed objects by fused deposition modeling (FDM) using commercial filaments without post-treatment processes. This generic approach has been demonstrated in objects using three different types of materials, Rhodamine B, ZnO nanoparticles (NPs), and Ciprofloxacin (Cip). The functionality of these objects is demonstrated through strong antibacterial activity in ZnO NPs and the controlled release of the antibiotic Cip. CMDF does not alter the mechanical properties of FDM-printed structures, can be applied with any type of FDM printer, and is, therefore, expected to have applications in a wide variety of fields.
RESUMO
This was a retrospective, descriptive study where human milk-derived fortifier (HMDF) was used to rescue infants intolerant to cow's milk-derived fortifier (CMDF). Rescue therapy was used for newborns with feed intolerance, systemic symptoms, or thrombocytosis. In a total of 412 very preterm infants (gestational age ≤ 32 wk) admitted to NICU during the study period, 14 infants met the rescue protocol inclusion criteria. The mean gestational age of these 14 infants was 29.2 ± 1.2 wk and birth weight was 1161 ± 201 g. All the infants who received rescue protocol by changing over to HMDF tolerated feeds well and showed a positive growth trend. Four infants had thrombocytosis, out of which 2 infants had elevated platelet count even with HMDF. Premature infants with intolerance to CMDF were effectively managed using HMDF as a rescue protocol. Infants tolerated HMDF well and showed positive growth trends till the discharge.